Mari Yoshida Selected Research

Mari Yoshida Research Topics

Disease

22	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 12/2006
22	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 03/2004
16	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2012
15	Sporadic Creutzfeldt-Jakob Disease 12/2021 - 06/2005
14	Tauopathies 11/2022 - 10/2006
14	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 05/2003
12	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 03/2004
11	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 05/2022 - 11/2004
10	Dementia (Dementias) 04/2021 - 02/2005
10	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 12/2019 - 11/2006
9	Corticobasal Degeneration 06/2022 - 10/2006
8	Multiple System Atrophy 01/2022 - 07/2005
8	Parkinson Disease (Parkinson's Disease) 01/2021 - 12/2003
7	TDP-43 Proteinopathies 01/2022 - 11/2008
6	Pick Disease of the Brain (Pick's Disease) 01/2022 - 10/2006
6	Synucleinopathies 01/2022 - 07/2012
6	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2020 - 03/2004
6	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2019 - 01/2013
5	Proteostasis Deficiencies 01/2021 - 11/2012
5	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 12/2013
5	Disease Progression 01/2017 - 06/2008
4	Cognitive Dysfunction 06/2022 - 09/2015
4	Gliosis 01/2022 - 11/2005
4	Akinetic Mutism (Coma Vigil) 12/2021 - 06/2014
4	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 11/2013
4	Multiple Sclerosis 01/2020 - 02/2008
4	Atrophy 11/2019 - 06/2005
4	Inflammation (Inflammations) 01/2019 - 02/2005
4	Acquired CJD 10/2018 - 02/2008
3	Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 01/2020 - 01/2016
3	Myoclonus (Nocturnal Myoclonus) 01/2019 - 06/2008
3	Diffuse Neurofibrillary Tangles with Calcification 01/2017 - 10/2006
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 02/2016 - 11/2009
3	Lewy Body Disease (Lewy Body Dementia) 09/2015 - 02/2005
2	Neuromyelitis Optica (Devic's Disease) 05/2022 - 06/2015
2	Amyloid Plaque 01/2022 - 12/2015
2	Amyloidosis 01/2022 - 12/2013
2	Nervous System Diseases (Neurological Disorders) 10/2021 - 11/2013
2	Neoplasms (Cancer) 04/2021 - 11/2017
2	Myelitis 01/2020 - 11/2016
2	Hemorrhage 01/2020 - 01/2012
2	Muscle Spasticity (Spastic) 02/2019 - 09/2012
2	Autoimmune Diseases of the Nervous System 05/2018 - 01/2017
2	Vasculitis (Vasculitides) 05/2018 - 01/2015
2	Brain Diseases (Brain Disorder) 01/2017 - 01/2012
2	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 02/2016 - 08/2012
2	Seizures (Absence Seizure) 01/2015 - 09/2012
1	Subacute Sclerosing Panencephalitis (SSPE) 11/2022
1	Muscle Weakness 08/2022
1	Neurolymphomatosis 08/2022
1	Lymphoma (Lymphomas) 06/2022

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2005
19	Prion ProteinsIBA 01/2020 - 06/2005
17	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 12/2006
11	UbiquitinIBA 07/2013 - 05/2003
10	SynucleinsIBA 01/2022 - 11/2011
10	AntibodiesIBA 01/2020 - 07/2008
9	Amyloid (Amyloid Fibrils)IBA 05/2022 - 12/2013
9	PrionsIBA 01/2022 - 01/2012
8	polyglutamineIBA 01/2018 - 03/2005
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2009
7	Codon (Codons)IBA 01/2019 - 11/2006
6	tau Proteins (tau Protein)IBA 10/2021 - 11/2004
6	sarkosylIBA 01/2020 - 07/2008
6	Protein Isoforms (Isoforms)IBA 01/2017 - 10/2006
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2013
5	alpha-SynucleinIBA 01/2022 - 03/2004
5	CytokinesIBA 11/2013 - 12/2003
4	Biological ProductsIBA 04/2021 - 11/2012
4	SteroidsIBA 01/2020 - 02/2008
4	Peptide Hydrolases (Proteases)FDA Link 02/2017 - 11/2006
3	Valosin Containing ProteinIBA 02/2014 - 11/2008
2	GadoliniumIBA 08/2022 - 09/2011
2	Methylprednisolone FDA LinkGeneric 06/2022 - 01/2017
2	InterferonsIBA 05/2022 - 06/2015
2	plexinIBA 12/2021 - 01/2021
2	Methionine (L-Methionine)FDA Link 12/2021 - 01/2016
2	Glial Fibrillary Acidic ProteinIBA 04/2021 - 01/2012
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 03/2005
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020 - 04/2011
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2019 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 02/2005
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2017
2	Peptides (Polypeptides)IBA 11/2017 - 12/2009
2	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 09/2015
2	3-Iodobenzylguanidine (Iobenguane)IBA 09/2015 - 01/2012
2	Immunoglobulin G (IgG)IBA 06/2015 - 07/2014
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2015 - 09/2012
2	Levodopa (L Dopa)FDA LinkGeneric 01/2012 - 01/2012
2	NucleotidesIBA 11/2009 - 08/2005
1	Antiviral Agents (Antivirals)IBA 11/2022
1	Hematoxylin (Haematoxylon)IBA 06/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2022
1	Microfilament Proteins (Actin Binding Proteins)IBA 05/2022
1	FilaminsIBA 05/2022

Therapy/Procedure

7	Therapeutics 11/2022 - 02/2008
4	Enteral Nutrition (Feeding, Tube) 12/2021 - 10/2011
4	Gastrostomy 01/2017 - 09/2012
2	Drug Therapy (Chemotherapy) 08/2022 - 08/2014
2	Tracheotomy 06/2016 - 07/2015